Towards a cell therapy for Parkinson’s Disease: Fully integrated closed system expansion and differentiation of pluripotent stem cells to mesencephalic dopaminergic progenitor cells
cost-effective innovative therapies. Using the versatile and integrated GMP cell processing platform, CliniMACS Prodigy®, we previously developed a cultivation and expansion workflow for PSCs. Now we have adapted

